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Edited by Maurice MontalAbstract An increasing number of peptides translocate the
plasma membrane of mammalian cells promising new avenues
for drug delivery. However, only a few examples are known to
penetrate the fungal cell wall. We compared the capacity of dif-
ferent ﬂuorophore-labelled peptides to translocate into ﬁssion
yeast and human cells and determined their intracellular distribu-
tion. Most of the 20 peptides tested were able to enter human
cells, but only one, transportan 10 (TP10), eﬃciently penetrated
ﬁssion yeast and was distributed uniformly inside the cells. The
results show that the fungal cell wall may reduce, but does not
block peptide uptake.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
Keywords: Cell-penetrating peptides; Human cells;
Schizosaccharomyces pombe1. Introduction
The cell membrane largely prohibits potential protein or
DNA-based therapeutic agents from reaching their intracellu-
lar targets. However, the discovery of peptides called cell-pe-
netrating peptides (CPPs) that have the ability to pass
through the plasma membrane and have the capacity to deli-
ver biomolecules into mammalian cells has attracted wide-
spread interest from pharmaceutical researchers. CPPs can
mediate the delivery of peptides, proteins, oligonucleotides
and plasmids into cells (reviewed in [1,2]). Bactericidal eﬀects
of peptides conjugated to antisense oligonucleotides or toxic
peptides have also been reported [3–6]. Fungicidal eﬀects of
toxic peptides like histatins were also demonstrated in the
pathogenic yeast, Candida albicans (reviewed in [7]). But in
fact, limited examples are available for peptides that pene-
trate the cell wall of budding yeast [4,6] and none is available
for ﬁssion yeast.*Corresponding authors. Fax: +1 819 564 5392.
E-mail addresses: Raymund.Wellinger@USherbrooke.ca
(R.J. Wellinger), Sherif.Abou.Elela@USherbrooke.ca (S.A. Elela).
0014-5793/$30.00  2005 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2005.07.064The ﬁssion yeast Schizosaccharomyces pombe is a classical
model for the study of the cell cycle that expresses many of
the genes known to control the human cell cycle [8]. However,
most drugs that easily penetrate mammalian cells do not freely
penetrate the fungal cell wall, hindering the use of S. pombe as
a tool to study the mechanism of action of drugs. Therefore,
we initiated a search for CPPs that may eventually function
as carriers for drugs that normally do not enter the cells of
S. pombe. We compared the free uptake of 20 ﬂuorescently la-
belled CPPs in S. pombe and human cells. As expected the re-
sults show that in general the human cell wall is easier to
penetrate when compared to the fungal cell wall. However,
one peptide TP10, eﬃciently entered both human and ﬁssion
yeast cells and was dispersed throughout the cytoplasm and
the nucleus.2. Materials and methods
Standard peptide (listed in Table 1) synthesis, yeast and mammalian
cell cultures were used in this study (see Supplementary material for
details).3. Results and discussion
3.1. Fluorescence detection by FACS analysis
To evaluate the capacity of CPPs to enter human and
yeast cells and provide a measure of the eﬃciency of cell
penetration, we incubated ﬂuorescein-labelled peptides with
HeLaS3 and S. pombe cells at diﬀerent concentrations (40–
50 lM). These high peptide concentrations did not seem to
be cytotoxic (data not shown and Supplementary material).
Before analysis of these cells by ﬂow cytometry, a mild pro-
tease digestion was performed with trypsin to prevent arte-
facts due to the adherence of CPPs to cell surface. At
40 lM CPP, the percentage of ﬂuorescent HeLaS3 cells var-
ied from 79% to 100% with the diﬀerent ﬂuorescently la-
belled CPPs (Fig. 1A). However, the mean ﬂuorescence
intensity, which describes the mean value of the shifted peak
of the green ﬂuorescence, varied from 2.37 to 207 (Fig. 1A).
Only six peptides had a mean ﬂuorescence intensity above
50. This indicates that while all CPPs assayed have theblished by Elsevier B.V. All rights reserved.
Table 1
Cell-penetrating peptidea sequences used in this study
Name Sequence
Penetratin f\-RQI KIW FQN RRM KWK K-amide
TAT f\-GRK KRR QRR RPP Q
MAP f\-KLA LKL ALK ALK AAL KLA-amide
TP f\-GWT LNS AGY LLG KIN LKA LAA
LAK KIL-amide
TP10 f\-AGY LLG KIN LKA LAA LAK KIL-amide
pVEC f\-LLI ILR RRI RKQ AHA HSK-amide
(KFF)3K f
\-KFF KFF KFF K
P189 f\-ETL TVH APS P
P190 f\-VLT NEN PFS DP
P191 f\-SIN NDA KSS
P192 f\-RGY TLI DL
P193 f\-PDE STK
P195 f\-IYA ASF WRP
P196 f\-SAT EWW HAA D
P197 f\-GSQ SSG KS
P198 f\-CGG ARI
P200 f\-PKK KRK V
P201 f\-PKT KRK V
Erns f\-RQG AAR VTS WLG LQL RIA GKR
LEG RSK-amide
KALA f\-WEA KLA KAL AKA LAK HLA KAL AKA
LKA CEA
f\: N-terminally ﬂuorescently label; amide: C-terminal amide.
aAll reviewed in [2,10] except Erns [25] and P189–P201 [5].
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enter eﬃciently into cells.
As also judged by FACS, the number of yeast cells that inter-
nalizeCPPs increasewith increasing peptide concentration (data
not shown). In addition, all ﬂuorescent-labelled peptides can en-
ter S. pombe cells, however, only six (penetratin, MAP, TP,
TP10, pVECandErns) can enter eﬀectively into cells, theirmean
ﬂuorescence being greater than 50 (Fig. 1B).Moreover, forTP10
and Erns, the mean ﬂuorescence intensity was 137 ± 29 andFig. 1. Comparisons between the mean ﬂuorescence intensity and the numb
cells incubated with 40 lM of ﬂuorescently labelled CPPs. (B) Freshly grown
Supplementary material). CTRL, untreated cells, ( ) mean ﬂuorescence int
average of three diﬀerent experiments.339 ± 52, respectively, which indicates that these CPPs internal-
ize with high eﬃciency into S. pombe cells.
3.2. Microscopic analysis
After incubation of the diﬀerent ﬂuorescently labelled CPPs
with human and yeast cells, non-ﬁxed cells were mounted on
micro slides and the percentage of ﬂuorescent cells was
evaluated manually by ﬂuorescence microscopy (Table 2).
The results corroborate the FACS data. Erns and TP10 had
a higher capacity to penetrate into S. pombe cells with
78.4 ± 10.6% and 50.8 ± 2.2% of ﬂuorescent cells, respectively.
We also tested the uptake eﬃciencies of the CPPs listed in Ta-
ble 1 into Saccharomyces cerevisiae yeast cells. However, the
budding yeast cellmembrane does not allow, or extremely limits,
penetration. The TAT peptide, scoring the highest values only
yielded 10.5% of ﬂuorescent cells; penetratin and TP yielded
5.7% and 4.9% ﬂuorescent cells, respectively (data not shown).
In the accompanying paper, Holm et al. [9] demonstrate the cel-
lular uptakeof penetratin, pVECand (KFF)3K intoS. cerevisiae
cells. Their experiments determined that pVEC is kinetically
more stable than the two others. Qualitatively, our results are
very similar. We observed that 5.7% of S. cerevisiae cells were
ﬂuorescent when incubated with FITC-labelled penetratin
whereas only 4.4% and 3.6% of ﬂuorescent cells were observed
following incubation with pVEC and (KFF)3K, respectively
(data not shown). Holm et al. [9] also show that penetratin,
although almost completely degraded, can enter S. cerevisiae
cells more eﬃciently than pVEC and (KFF)3K.
3.3. Intracellular distribution by microscopic analysis
The intracellular distribution of the various ﬂuorescence-la-
belled CPPs was assayed by ﬂuorescence microscopy on
non-ﬁxed cells incubated with the CPPs and with Hoechst, a
nuclear-staining dye.
In three human cell lines assayed, any given peptide dis-
played identical intracellular distribution patterns (Table 3).
For example, the TP peptide was almost uniformly distributeder of ﬂuorescent cells (%) as evaluated by FACS analysis. (A) HeLaS3
S. pombe cells treated with 50 lM of ﬂuorescently labelled peptides (see
ensity, ( ) percentage ﬂuorescent cells. Each bar graph represents the
Table 2
Percentage of ﬂuorescent cells observed by ﬂuorescence microscopya













Penetratin 643 643 100 30 730 4.1 ± 1.2
TAT 1025 1028 99.7 ± 2.3 38 727 5.2 ± 2.0
MAP 740 740 100 30 655 4.6 ± 1.8
TP 761 761 100 353 1375 25.7 ± 1.8
TP10 1267 1267 100 948 1868 50.8 ± 2.2
pVEC 790 790 100 20 344 5.8 ± 1.0
(KFF)3K 726 726 100 143 1100 13.0 ± 3.2
P189 372 431 86.3 ± 8.6 8 400 2.0 ± 0.8
P190 169 170 99.4 ± 0.4 8 2289 0.3 ± 1.1
P191 26 1026 2.5 ± 5.8 2 1094 0.2 ± 1.1
P192 44 2044 2.2 ± 5.8 9 1365 0.6 ± 1.2
P193 151 152 98.1 ± 14.4 4 479 0.8 ± 0.3
P195 218 1218 17.9 ± 5.8 11 1368 0.8 ± 1.9
P196 219 219 100 11 1408 0.8 ± 1.6
P197 810 830 97.6 ± 9.6 4 1356 0.3 ± 0.6
P198 709 709 100 21 1516 1.4 ± 2.0
P200 1 204 0.5 ± 0.3 6 1383 0.4 ± 0.6
P201 10 2020 0.5 ± 2.9 7 1346 0.5 ± 0.8
Erns 352 352 100 391 499 78.4 ± 10.6
KALA 253 253 100 2 301 0.7 ± 0.4
aAverage of at least three uptake experiments: 50 lM for 1 h at 30 C for yeast cells and 40 lM for 1 h at 37 C for HeLaS3 cells. The
concentration of CPPs has been chosen to observe 50% of ﬂuorescent cells with the best CPP for S. pombe cells, i.e., TP10 (see Table 3 and Fig. 5). A
time-course has been done to establish the incubation time; after 1 h, the percentage of ﬂuorescent S. pombe cells began to diminish (data not shown).
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optical sectioning proved that the peptide was internalized and
not simply bound to the surface of the cells (Fig. 3A). Regard-
ing MAP peptide, it was almost exclusively localized to the nu-
cleus, with only low signals observed in the cytoplasm (Figs.
2B and 3B), whereas the TAT peptide was predominantly
localized in the cytoplasm (Fig. 2C). Some peptides seemed
to have a punctuated localization (see KALA peptide,Table 3
Intracellullar distribution of CPPs
Peptides Intracellular distribution
Human cellsa S. pombe
Penetratin N C
TAT C PC
MAP N N, C
TP N, C N, C
TP10 N, C N, C
pVEC N, C, M N, C
(KFF)3K N, C N, C
P189 PN, PC PC
P190 PC PC
P191 PC PC
P192 PC, PN C
P193 PN C
P195 PN C
P196 PC, M C
P197 M PC





N, nucleus; C, cytoplasm; M, membrane; PN, punctuated signal in
nucleus; PC, punctuated signal in cytoplasm.
aHeLaS3, HCT 116 and PC3 cell lines.Fig. 3C) while others had a membrane-associated localization
(such as P196, Fig. 3D).
In S. pombe cells, among the most eﬃcient CPPs (Table 2),
Erns had a punctuated cytoplasmic distribution (Table 3 and
Fig. 5A), whereas TP10 was dispersed throughout the cyto-
plasm and the nucleus (Table 3, Figs. 4 and 5B). Moreover,
we veriﬁed whether the internalized ﬂuorescence is consistent
with intact TP10 peptide and this was the case (see Supplemen-
tary material).
The mechanism of CPP-directed cellular uptake has been
controversial and is not fully elucidated [10]. In fact, the
mechanism by which the CPP translocates into the cells
could inﬂuence its intracellular distribution. Initially, it was
assumed that CPPs such as TAT and penetratin, translocate
across plasma membranes via an energy-independent mecha-
nism [11–13], which circumvents endocytic uptake [14].
However, following the discovery that the use of cell ﬁxation
agents can cause artefacts during ﬂuorescence microscopy
[15], recent studies have re-evaluated the uptake mechanism
of TAT and penetratin. Some groups reported that TAT
and penetratin in HeLa cells are found in cytosolic vesicles,
suggesting penetration via an endosomal pathway [15–17],
whereas others reported that TAT is localized in nucleolus
[18] and in the nucleus [19]. In the present study, TAT
was found predominantly in the cytoplasm but not in cyto-
solic compartments (Fig. 2C and Table 3), and penetratin
was mainly observed in the nucleus in HeLaS3 cells (Table
3), in agreement with Nakase et al. [20]. In addition, several
studies show that the internalization of CPPs is dependent
on the cell speciﬁc membrane components or lipid composi-
tion, which varies from cell line to cell line [21–23]. More-
over, Ha¨llbrink et al. [24] demonstrated that the uptake of
CPPs is linked to the peptide-to-cell ratio rather than to
the peptide concentration.
Fig. 2. Intracellular distribution of diﬀerent CPPs in human cells. (A) and (B), HCT 116 (C), HeLaS3 cells incubated with 40 lM of ﬂuorescently
labelled CPPs and treated with 2 lg/ml of Hoechst.
Fig. 3. Intracellular distribution of CPPs in human cell lines as examined by optical sectioning. Human cells treated with 40 lM of ﬂuorescence-
labelled CPPs were subjected to optical sectioning using a confocal laser microscope. The focus plane was moved from bottom to top in the vertical
axis at an interval of 1.0 lm. Cell lines and CPPs used are indicated above each panel.
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Fig. 4. Intracellular distribution of TP10 in S. pombe cells. Freshly grown S. pombe cells were incubated with 50 lM of ﬂuorescently labelled TP10
and treated with 2 lg/ml of Hoechst.
Fig. 5. Intracellular distribution of CPPs in S. pombe cells as examined by optical sectioning. S. pombe cells treated with 50 lM of ﬂuorescence-
labelled CPPs were subjected to optical sectioning using confocal laser microscopy. The focal plane was moved from bottom to top in the vertical axis
at an interval of 1.0 lm. CPPs used are indicated above each panel.
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For years, the yeast cell wall was considered as an impen-
etrable outer surface because of its thickness and rigidity.
Our data demonstrate that the cell wall of S. pombe does
not prevent CPP-uptake and moreover, it is more permissive
than that of S. cerevisiae (Fig. 1, Table 2 and data not
shown).
Although Erns peptide shows the highest uptake (Fig. 1
and Table 2), the TP10 peptide is the most promising for
yeast, considering that this peptide is distributed uniformly
inside ﬁssion yeast cells whereas Erns has a punctuated
localization (Fig. 5 and Table 3). For the human cell lines
used (HeLaS3, HCT 116 and PC3), MAP and penetratin
seem to be the best peptides to translocate into nucleus;
TP and TP10 seem to perform best, as they
dispersed throughout the cell, whereas TAT only enters
the cytoplasm.
It will be of interest to test whether TP10 can serve as a car-
rier to deliver antisense oligonucleotides and siRNAs into S.
pombe cells, which would facilitate the determination of
cellular functions of uncharacterized genes and the mechanism
of action of diﬀerent drugs. Moreover, the entry of CPPs into
ﬁssion yeast opens the way toward the use of CPPs to deliver
biomolecules in other organisms with a strong cell wall like
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Supplementary data associated with this article can be found,
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